ONCOLOGIX TECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | 0.00% |
|
0.00% | -92.00% |
| 2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
| 2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
| Sales 2013 | 0.24 0.33 | Sales 2014 | 3.68 5.03 | Capitalization | 758K 1.04M |
|---|---|---|---|---|---|
| Net income 2013 | - 0 | Net income 2014 | -1M -1.37M | EV / Sales 2013 | 8,716,069 x |
| Net Debt 2013 | 1.33M 1.82M | Net Debt 2014 | 1.89M 2.59M | EV / Sales 2014 | 721,342 x |
| P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | 191 |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More press releases
| Current month | +100.00% | ||
| 1 month | +100.00% | ||
| 3 months | +100.00% | ||
| 6 months | -71.43% | ||
| Current year | -92.00% |
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.02
5 years
0.000.02
10 years
0.000.02
| Managers | Title | Age | Since |
|---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
Nikole Jessie
IRO | Public Communications Contact | - | 15-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
Oncologix Tech, Inc. is a shell company. The Company is a non-operating holding Company. The Company has no operations. The Company seeks to acquire an operating company via reverse merger.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| -92.00% | 332K | |
| +166.80% | 5.68B | |
| +1.65% | 1.01B | |
| +2.05% | 982M | |
| +41.91% | 872M | |
| +24.28% | 819M | |
| +1.72% | 663M | |
| +1.80% | 610M | |
| -.--% | 600M | |
| +36.55% | 552M |
- Stock Market
- Equities
- OCLG Stock
